NO147034B - PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASSES - Google Patents
PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASSES Download PDFInfo
- Publication number
- NO147034B NO147034B NO772658A NO772658A NO147034B NO 147034 B NO147034 B NO 147034B NO 772658 A NO772658 A NO 772658A NO 772658 A NO772658 A NO 772658A NO 147034 B NO147034 B NO 147034B
- Authority
- NO
- Norway
- Prior art keywords
- cell mass
- solvent
- water
- cell
- ammonia
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 24
- 150000002632 lipids Chemical class 0.000 title claims description 18
- 150000007523 nucleic acids Chemical class 0.000 title claims description 15
- 102000039446 nucleic acids Human genes 0.000 title claims description 15
- 108020004707 nucleic acids Proteins 0.000 title claims description 15
- 230000000813 microbial effect Effects 0.000 title claims description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 66
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 37
- 239000002904 solvent Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 229910021529 ammonia Inorganic materials 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000000908 ammonium hydroxide Substances 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 45
- 239000000463 material Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 244000005700 microbiome Species 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000013049 sediment Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 230000009965 odorless effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000004131 EU approved raising agent Substances 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000589344 Methylomonas Species 0.000 description 1
- 241000589341 Methylomonas clara Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/08—Reducing the nucleic acid content
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Extraction Or Liquid Replacement (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
Oppfinnelsen vedrører en fremgangsmåte til nedsettelse av lipid- og nukleinsyremengden som er inneholdt i mikro-organismece1 le r .. Hver celle inneholder kullhydrater, pro-teiner, lipider og nukleinsyrer. Anvendbarheten av mikrobielle cellemasser som næringsmiddel og foringsmiddel påvirkes nega- The invention relates to a method for reducing the amount of lipid and nucleic acid contained in micro-organism cells. Each cell contains carbohydrates, proteins, lipids and nucleic acids. The applicability of microbial cell masses as food and fodder is negatively affected
tivt ved innhold av nukleinsyrer og lipider. tive by the content of nucleic acids and lipids.
Et nukleinsyreinnhold er uønsket da det fører A nucleic acid content is undesirable as it leads
til patologiske tilstander (gikt, urinstener). Lipider begrenser lagringsevnen ved å bli harskt og påvirker smaken. to pathological conditions (gout, urinary stones). Lipids limit shelf life by becoming rancid and affecting taste.
Oppfinnelsens oppgave er derfor å senke lipid- The task of the invention is therefore to lower the lipid
og nukleinsyreinnholdet i mikrobielle cellemasser. Etter kjente fremgangsmåter utløses lipidene enten fra celleveggen og mem-branen ved organiske oppløsningsmidler eller forsåpes ved behandling med vandige alkalier. and the nucleic acid content of microbial cell masses. According to known methods, the lipids are either released from the cell wall and membrane by organic solvents or saponified by treatment with aqueous alkalis.
En kjent fremgangsmåte til utløsning av lipidene fra mikroorganismer arbeider med blandinger av metanol og kloro-form. Fremgangsmåten er omstendlig og kan føre til toksiske produkter. Lipidekstraheringer med alkohol-vannblandinger (ifølge DOS 2 405 593 eller 2 137 038) egner seg dårlig for bakterier og er likeledes omstendlig i den tekniske utførelse. A known method for releasing the lipids from microorganisms works with mixtures of methanol and chloroform. The procedure is cumbersome and can lead to toxic products. Lipid extractions with alcohol-water mixtures (according to DOS 2 405 593 or 2 137 038) are not suitable for bacteria and are likewise cumbersome in the technical execution.
Videre kjente fremgangsmåter til å gjøre mikrobielle cellemasser nukleinsyre- og lipidfattige anvender den alkaliske oppslutning ved forhøyede temperaturer. Uheldig er herved frigjøringen av de ved hydrolysen dannede fri fettsyrer som utskiller seg sammen med proteinet. Furthermore, known methods for making microbial cell masses nucleic acid- and lipid-poor use alkaline digestion at elevated temperatures. Unfortunate is the release of the free fatty acids formed during the hydrolysis, which are secreted together with the protein.
Dessuten går en del av de i proteinet inne-holdte essensielle aminosyrer, f.eks. lysin,over i en for organ-ismen ikke utnyttbar tilstand. In addition, part of the essential amino acids contained in the protein, e.g. lysine, left in a state that cannot be used by the organism.
Oppfinnelsen vedrører en fremgangsmåte for nedsettelse av lipid- og nukleinsyreinnholdet i mikrobielle cellemasser ved å ekstrahere cellemassen med oppløsningsmiddel og ammoniakk,fraskille ekstraktet samt vaske og tørke cellemassen, The invention relates to a method for reducing the lipid and nucleic acid content in microbial cell masses by extracting the cell mass with solvent and ammonia, separating the extract and washing and drying the cell mass,
idet fremgangsmåten er karakterisert ved at man i et første trinn ekstraherer cellemassen med en ekstraheringsblanding inneholdende ammoniakk eller ammoniumhydroksyd og et organisk oppløsningsmiddel med formel in that the method is characterized by the fact that in a first step the cell mass is extracted with an extraction mixture containing ammonia or ammonium hydroxide and an organic solvent with the formula
hvori R1 og R2 betegner et hydrogenatom og n betyr 1, 2 eller 3 innberegnet isopropanol, eller hvori R-^ betyr en hydroksygruppe og R2 betyr et hydrogenatom eller en metyl- eller etylgruppe, og n er 2 eller 3, under normaltrykk og ved en temperatur mellom in which R1 and R2 denote a hydrogen atom and n means 1, 2 or 3 including isopropanol, or in which R-^ means a hydroxy group and R2 means a hydrogen atom or a methyl or ethyl group, and n is 2 or 3, under normal pressure and at a temperature between
-20 og +60°C i en tid på maksimalt 120 minutter, idet det totale vanninnhold under ekstraksjonen er 0-30 vekt-% beregnet på mengden av det anvendte oppløsningsmiddel, og idet hvis oppløsningsmidlet utgjøres av metanol eller etanol, vektforholdet mellom cellemasse, oppløsningsmiddel og ammoniakk er 1:3:0,03-1:6:0,6, fortrinnsvis 1:3:0,03-1:6:0,3 , og hvis oppløsningsmidlet utgjøres av propanol, glykol eller monoglykoleter, 1:8:0,08-1:12:1,2, fortrinnsvis 1:8:0,08-1:12:0,6, og at man i et annet trinn etter at ekstraher-ingsblandingen er separert, vasker cellemasseresiduet med vann med en pH-verdi på 5-8,5 og en temperatur på 30-95°C og normal- -20 and +60°C for a maximum of 120 minutes, the total water content during the extraction being 0-30% by weight calculated on the amount of the solvent used, and if the solvent is methanol or ethanol, the weight ratio between cell mass, solvent and ammonia is 1:3:0.03-1:6:0.6, preferably 1:3:0.03-1:6:0.3, and if the solvent consists of propanol, glycol or monoglycol ether, 1: 8:0.08-1:12:1.2, preferably 1:8:0.08-1:12:0.6, and that in another step after the extraction mixture has been separated, the cell mass residue is washed with water with a pH value of 5-8.5 and a temperature of 30-95°C and normal
trykk i en tid på 5-120 minutter, idet vektforholdet av vannmengde og cellemasse er 1:1-1:30, hvoretter man adskiller vannfasen, eventuelt ekstraherer cellemassen med det organiske oppløsnings- pressure for a time of 5-120 minutes, with the weight ratio of water quantity and cell mass being 1:1-1:30, after which the water phase is separated, possibly extracting the cell mass with the organic solvent
midlet med formel I, og tørker cellemassen. the agent of formula I, and dries the cell mass.
Som mikrobielle cellemasser anvendes fortrinns- As microbial cell masses are preferably used
vis mikroorganismer som f.eks. er frembragt ved dyrking på alkohol eller n-parafiner i nærvær av et vandig næringsmedium og en fri oksygenholdig gass. Foretrukket som mikroorganismer er bakterier, gjær og sopp. show microorganisms such as is produced by cultivation on alcohol or n-paraffins in the presence of an aqueous nutrient medium and a free oxygen-containing gas. Preferred micro-organisms are bacteria, yeast and fungi.
Eksempler på slike mikroorganismer er metanol-utnyttende bakterier av slekten Metylomonas, f.eks. Metylomonas clara ATCC 31226, eller gjær som Candida lipolytica ATCC 20383 som kan fåes ved dyrking på n-parafiner i nærvær av et vandignæringsmedium. Examples of such microorganisms are methanol-utilizing bacteria of the genus Metylomonas, e.g. Methylomonas clara ATCC 31226, or yeasts such as Candida lipolytica ATCC 20383 which can be obtained by cultivation on n-paraffins in the presence of an aqueous nutrient medium.
Tørkede soppmycelier kan likeledes anvendes. Dette cellematerial kan uttas fra antibiotikafremstilling, eksempelvis fra penicillinfermentering etter at antibiotika ble ekstrahert. Dried mushroom mycelia can also be used. This cell material can be taken from antibiotic production, for example from penicillin fermentation after the antibiotic has been extracted.
Som oppløsningsmiddel med formel I kommer det i betraktning alkoholer som metanol, etanol, n-propanol og isopropanol. Foretrukket er metanol og etanol, spesielt metanol. Foruten de nevnte alkoholer egner det seg glycoler og deres monoeter med formel I, nemlig glykol og monometylglykol. As solvent with formula I, alcohols such as methanol, ethanol, n-propanol and isopropanol come into consideration. Preferred are methanol and ethanol, especially methanol. In addition to the alcohols mentioned, glycols and their monoethers of formula I, namely glycol and monomethylglycol, are suitable.
Ammoniakk kan settes til de nevnte oppløsnings-midler gassformet (NH-) eller som konsentrert vandig oppløsning (NH^OH). Valget foregår etter celletørrmaterialets vanninnhold samt etter mengden og vanninnhold av anvendt oppløsningsmiddel. NH^OH egner seg ved cellemasser ved lavt fuktighetsinnhold (0-15%), NH^ derimot bedre ved cellemasser ved høyere vanninnhold (10-30%). Ammonia can be added to the aforementioned solvents in gaseous form (NH-) or as a concentrated aqueous solution (NH^OH). The selection takes place according to the water content of the cell dry material as well as the amount and water content of the solvent used. NH^OH is suitable for cell masses with a low moisture content (0-15%), NH^, on the other hand, is better for cell masses with a higher water content (10-30%).
Mengden av lipider som fjernes ved ekstrahering med ammoniakkoppløsningsmidler avhenger av det samlede vanninnhold som refererer til vekt-* på den anvendte oppløsningsmiddelmeng- The amount of lipids removed by extraction with ammonia solvents depends on the total water content which refers to the weight* of the amount of solvent used.
de og av NH^-konsentrasjonen i vekt-% refererer til anvendt opp-løsningsmiddel . de and of the NH^ concentration in % by weight refer to the solvent used.
Spesielt gode forsøksresultater lar det seg oppnå Particularly good test results can be achieved
ved cellemasse/oppløsningsmiddelvektforhold på 1 : 3 til 1 : 6 at cell mass/solvent weight ratios of 1:3 to 1:6
ved metanol og etanol, og 1 : 8 til 1 : 12 ved propanol, glykol og monoglykoler etter denne. Ammoniakk-konsentrasjonen referert til oppløsningsmiddelmengde utgjorde 1-10 vekt-%, fortrinnsvis 1-5 vekt-%. Summen av vannmengdene som stammer fra cellemasse-oppløsningsmiddel og eventuelt var vanndig ammoniakk, utgjorde 0-30 vekt-%, fortrinnsvis 0 - 20 %, spesielt 0-10 vekt-%, referert til den anvendte oppløsningsmiddelmengde. with methanol and ethanol, and 1 : 8 to 1 : 12 with propanol, glycol and monoglycols after this. The ammonia concentration referred to the amount of solvent was 1-10% by weight, preferably 1-5% by weight. The sum of the amounts of water originating from cell mass solvent and possibly aqueous ammonia amounted to 0-30% by weight, preferably 0-20%, especially 0-10% by weight, referred to the amount of solvent used.
Ved arbeider i teknisk målestokk kan det ses bort For work on a technical scale, it can be disregarded
fra en tørkning av cellen etter fermentering inntil et mindre restvanninnhold på 4% eller lavere. Det er tilstrekkelig å from a drying of the cell after fermentation until a minor residual water content of 4% or lower. It is sufficient to
bringe cellemassen til en slikt celletørrvekt at etter tilset-ning av den nødvendige oppløsningsmiddelmengde, ligger det samlede vanninnhold i det optimale område, eventuelt vil man til oppløsningsmiddelet sette gassformet NH^. bring the cell mass to such a cell dry weight that, after adding the required amount of solvent, the total water content is in the optimum range, optionally adding gaseous NH 2 to the solvent.
Oppløsningen av fett fra de mikrobielle cellemasser gjennomføres således at cellematerialet suspenderes i det organiske oppløsningsmiddel med formel I og NH^ innføres eller NH^OH tilsettes. Hensiktsmessig er gjennomblandingen av suspensjonen ved hjelp av røring. Behandlingstemperaturen ligger • The dissolution of fat from the microbial cell masses is carried out in such a way that the cell material is suspended in the organic solvent of formula I and NH 3 is introduced or NH 3 OH is added. It is appropriate to thoroughly mix the suspension by means of stirring. The treatment temperature is •
i området fra -20° til +60°C idet det er foretrukket et område fra +5° til +50°C og spesielt fra +lo° til +30°C. Behand-lingsvarigheten utgjør opptil 120 minutter og ligger fortrinnsvis ved 25 - 35 minutter. Behandlingen gjennomføres ved normalt trykk. in the range from -20° to +60°C, with a range from +5° to +50°C and especially from +lo° to +30°C being preferred. The treatment duration is up to 120 minutes and is preferably 25 - 35 minutes. The treatment is carried out at normal pressure.
Etter avslutning av oppløsningsmiddel-/ammoniakkbe-handlingen adskilles det dannede cellematerial (proteinet) After completion of the solvent/ammonia treatment, the formed cell material (the protein) is separated
etter ønskelige fremgangsmåter som sentriifugering, filtrering og sedimentering fra oppløsningsmiddelet. following desirable methods such as centrifugation, filtration and sedimentation from the solvent.
Filtrering foretrekkes. Det dannede faste cellematerial kan for best mulig fullstendig fjerning av lipider igjen . behandles med et at de nevnte organiske oppløsningsmidler. Filtering is preferred. The formed solid cell material allows for the best possible complete removal of lipids again. treated with one of the aforementioned organic solvents.
Residuet kan for fjerning av oppløsningsrester og ammoniakk tørkes. Hensiktsmessig gjennomføres dette under- néd-;:satt..';trykk i fortrinnsvis 80 - 150 torr og forhøyet temperatur, fortrd/rin"s vi' s'• *»0° "- -5'0°C'. Det således avfettede og tørkede produkt 'ér-llfK t-1'øst'; • ;'-'-- " The residue can be dried to remove solution residues and ammonia. Appropriately, this is carried out under reduced pressure, preferably 80 - 150 torr and elevated temperature, fortrd/rin"s vi' s'• *»0° "- -5'0°C'. The thus defatted and dried product 'ér-llfK t-1'est'; • ;'-'-- "
- TV' ';<;>>:ir' Den etter" ovennevnte 'fremgangsmåte fra det faste cellemateriale adskilte flytende fase inneholder ammoniakk og opp lø s-t "lipid-.- Det anvendte oppløsningsmiddel- kan adskilles ved våkuumdestillas j on', f ra' fet tene og" igjen ' anvendes ."' - TV' ';<;>>:ir' The liquid phase separated from the solid cell material by the above-mentioned method contains ammonia and dissolved lipids. The solvent used can be separated by vacuum distillation, from ' fat tene and" again ' is used."'
<:> •*.'■>. Deretter opptas de avféttede og eventuelt tørkede cellemasser i ■ : .'~ : vannmengder som til celle- '' massehstår i - vekt forhold 1' :: 1't'i'l • 1 : 30-^'spesielt i :' 5til' ' ' '; <:> •*.'■>. The degreased and possibly dried cell masses are then taken up in ■ : .'~ : amounts of water which to the cell- '' mass hsts in - weight ratio 1' :: 1't'i'l • 1 : 30-^'especially in :' 5til ' ' ' ';
1 :■■ 1-5-'Wanrimengden- 'damfensj:cn-ér¥s3mih'st':'såiedés-• åt det' er mulig med en - omrøring'-' av- suspens j bhen"! ' "-v ' • '' 1 :■■ 1-5-'Wanrimenden- 'damfensj:cn-ér¥s3mih'st':'såiedés-• ate it' is possible with a - stirring'-' of- suspension j bhen"! ' "-v '•''
• - '.' •■' p'H-v'érdien under-''vannbehandlingen :skal ' ligger 'i området på 5 - 8 ,5, fortrinnsvis^ 6''-;'-7 ,5^'bg'innstilles'eventuelt '' på dette - området -. ■" Dette- ér 1 spesielt nød vend ig'-når : det "'anvendes ikke eller 'ikke fullstendig'-tørkede cellemasser fra første -' *' ' trinn som'deretterrogså:déssuten-inneholder restméngder ammoniakk, hvilket kan føre til en for høy pH-verdi . - -. - :'-'Ekstraheringen: av'nucleinsyre,' salter, poiysaccari-der og'vannoppløselig-sekundærmetabolitermed vann gjennomføres i et t emperaturområde pa'■ 30°'-- 95°C - ved normalt 'trykk'.' Foretrukket er'témperaturéf på 4 0° - 70°C/spesielt foretrukket 50° - :-6..0°C .':' 'E k s t r åh e f i ri'g s v å r i'g h e t e ir' •' k a n 'al*t etter ekstra'riérings-temperatur -'-og'.vannmengde (utgjøre 5 :''-'"l'20 minutter. -Gode Te sul-tater ."oppnår -man 'med '"-25 ••-' :4'5' 'minutters ékstrarieririgstid. For ' "•" adskillelse"<v>a"v- fa'st'e:"og flytende bestandderer' sentrifugeres' "'' suspensjonen','-'' fortriri-risvis' ved temperaturer på 10° -'30°C<L>:' Andre' egnede 'ski llef remgairgsmater :'er sedimentas j on og filtrering-.-' .'»*.' • For et > !<*i'e r e -' a d s 1< i 1 i e l's e ! å v'' ' c' e' l 1 e rna s se n 'tilsettes fortrinr.svis til vannet ved ar.net trinn inntil 20 vekt'-*' for- ' tri nr.s vi?-'-'5 -'" ]'=*"•• vÆ:-'7 :'av'"en lavere alkbhol' 'som-etanol, metanol, f crtr.'.-hn's'V-ib'-'niev anbl'.' "■ "' ■ -■'' : 1 ' -<:>• - '.' •■' p'H-v'érdien during the-'''water treatment: must be 'in the range of 5 - 8 .5, preferably^ 6''-;'-7 .5^'bg'set'if necessary'' in this - area -. ■" This is particularly necessary when: it is "not used or not completely dried cell masses from the first step which then contain residual amounts of ammonia, which can lead to a pH value too high. - -. The extraction: of nucleic acid, salts, polysaccharides and water-soluble secondary metabolites with water is carried out in a temperature range of 30°--95°C - at normal pressure. Preferred is a temperature of 40° - 70°C/especially preferred 50° - :-6..0°C. according to extra'riération temperature -'-and'.quantity of water (make up 5:''-'"l'20 minutes. -Good tea sul-tates ."achieved -one 'with '"-25 •• -' :4'5' 'minutes extraction time. For' "•" separation"<v>a"v- solid:"e:"e" and liquid constituents' are centrifuged' "'''' suspension'','-'' triri- ricewise' at temperatures of 10° -'30°C<L>:' Other' suitable 'ski llef remgairgsmater :'er sedimentas j on and filtration-.-' .'»*.' • For a > !<*i 'e r e -' a d s 1 < i 1 i e l's e ! å v'' ' c' e' l 1 e rna s se n 'is preferably added to the water at ar.net steps up to 20 weight'-*' for - ' tri no.s vi?-'-'5 -'" ]'=*"•• vÆ:-'7 :'av'"a lower alkbhol' 'as-ethanol, methanol, f crtr.'.- hn's'V-ib'-'niev anbl'.' "■ "' ■ -■'' : 1 ' -<:>
-.<" -" - Den' f as te: "f ase' :b é f r'£e s''"e 11 e v "vanlig fremgangsmåte -.<" -" - Den' f as te: "f ase' :b é f r'£e s''"e 11 e v "ordinary procedure
som fryse-, vakuum- eller f cr s t^ vhihgs t'ø r'k ni ng f or væskerester.' Produktet'- -h!år- gbd'e- lukt<;>segénskaper'v'''eri lysere -fa;rve' eriif utgangs-material%-t bg—én" srieM el;t'v gb'd: vånnbrhdlngsevne .' For' fjerning' aV J lipidene ogiT/ucléansyrehevegr.or"' det '-'ser spesielt til 'fremstil'-' '* c ling av--J'nærihgs-:;'og;-Toririg^midler.^ ;,; • ■' ■' such as freezer, vacuum or f cr s t^ vhihgs t'ø r'k ni ng f or liquid residues.' The product'- -h!year- gbd'e- odor<;>segéncreas'v'''eri lighter -color;r;eri' than starting-material%-t bg—én" srieM el;t'v gb'd: water absorption capacity.' For the removal of lipids and ucléanic acid raising agents, it is particularly important to produce ; • ■' ■'
Således er ved produktet lipidene fjernet inntil et restinnhold fra 0,5 til 3,5 vekt-% nucle-insyre inntil et restinnhold på 0,5 - 4,5 vekt-%. Thus, in the product, the lipids have been removed up to a residual content of from 0.5 to 3.5% by weight nucleic acid up to a residual content of 0.5 - 4.5% by weight.
Fremgangsmåten ifølge oppfinnelsen unngår ulempene The method according to the invention avoids the disadvantages
ved de kjente fremgangsmåter som oppløsningsmiddel, behandling eller alkalisk oppslutning.KKlorerte hydrokarboner kreves ikke. Avfettningen med ammoniakk/oppløsningsmiddel.blandinger er spesielt ved bakterier vesentlig mer fullstendige enn ved behandling av cellemasser med oppløsningsmiddel/vannblandinger. Ek-streme temperaturer- og pH-områder som nedsetter produktets an-vendbarhet unngås. Energiforbruket, .er, mindre, enn. ved de kjente, alkaliske oppslutningsfremgangsmåter. Proteinanrikninger, lykkes uten dannelse av større mengder av nøytralisasjonssalter. by the known methods such as solvent, treatment or alkaline digestion. Chlorinated hydrocarbons are not required. The degreasing with ammonia/solvent mixtures is, especially with bacteria, significantly more complete than when treating cell masses with solvent/water mixtures. Extreme temperature and pH ranges that reduce the product's usability are avoided. The energy consumption is less than by the known alkaline digestion methods. Protein enrichments succeed without the formation of large amounts of neutralization salts.
Den fra fast cellematerial adskilte.vandige fase inneholder ved siden av andre- vannoopløselige bestanddeler, -nu-, eleinsyrene som kan utvinnes etter kjente fremgangsmåter, f.eks., ved utfelling i surt medium, ultrafiltrering, dialyse eller ,en-z/mbehandling. The aqueous phase separated from solid cell material contains, in addition to other water-soluble constituents, the oleic acids, which can be recovered according to known methods, for example, by precipitation in an acidic medium, ultrafiltration, dialysis or en-z/m treatment .
Oppfinnelsen .skal. forklares nærmere, ved hjelp av-.-.. noen eksempler. The invention .shall. is explained in more detail, with the help of-.-.. some examples.
Eksempel 1 .. Example 1 ..
Metylomonas cia ra ATCC 31226 ,ble.dyrket i en r.æ-ringsoppløsning inneholdende metanol som,eneste karbonkilde,. ammoniakk son eneste nitrogenkilde.,. f osf at, ■ j ern-, magnesium- . salter og andre vanlige sporelementer under aerobe betingelser. Den derved frembragte bakteriecellemasse ble adskilt.£ra opp-løsningen og underkastet f orstøvningstørkning . Methylomonas cia ra ATCC 31226 was grown in a stirring solution containing methanol as the sole carbon source. ammonia son sole source of nitrogen.,. f osf that, ■ j ern-, magnesium- . salts and other common trace elements under aerobic conditions. The resulting bacterial cell mass was separated from the solution and subjected to dust drying.
100 g av denne cellemasse ble .blandet med 300:g-, metanol. Under omrøring av suspensjonen ble det innført og opp-løst 10 g NK^-gass. Ved avkjøling ble .temperaturen under inn-føringen holdt ved .25 - .3.5°Cr :Blandingen av .metanol,- ammoniakk, 100 g of this cell mass was mixed with 300 g of methanol. While stirring the suspension, 10 g of NK2 gas was introduced and dissolved. During cooling, the temperature during the introduction was kept at 25 - 3.5°Cr: The mixture of methanol, ammonia,
og cellemasse ble omrørt 30 minutter ved 20°C........ and cell mass was stirred for 30 minutes at 20°C........
For adskillelse av den faste, og.. f ly tend.e fase ble For separation of the solid, and.. f ly tend.e phase was
det filtrert og det faste, res.idum vasket en gang med;.,300 mi metanol. Etter gjentatt filtrering ble begge filtrater forenet..--Denne brune oppløsning inneholdt lipidene av det anvendte ut-gangsstoff. Metanol cg ammoniakk :ble fjernet, ved vakuumdesti-lering (100 torr, 4 0°C)-.. Residuet som utgjorde 9,5-vekt-% ay det anvendte cellematerial var en mørkebrun pasta, med dårlig lukt som besto av fri fettsyrer, .gly cerider.,. fosf olip.i-der og sekundærmetaboliter. the filtrate and the solid residue were washed once with 300 ml of methanol. After repeated filtration, both filtrates were combined..--This brown solution contained the lipids of the starting material used. Methanol and ammonia were removed by vacuum distillation (100 torr, 40°C). The residue, which constituted 9.5% by weight of the cell material used, was a dark brown paste, with a bad smell, consisting of free fatty acids. , .glycerides.,. phospholipids and secondary metabolites.
Det ved filtreringen dannede faste residum av den ekstraherte cellemasse ble tørket i vakuum (100 torr) ved 40°C i 5 timer. Det kunne således fås 90 g avfettet cellemasse som var uten lukt og hadde en lysere farve enn utgangsmaterialet. The solid residue formed by the filtration of the extracted cell mass was dried in vacuum (100 torr) at 40°C for 5 hours. Thus, 90 g of defatted cell mass could be obtained which was odorless and had a lighter color than the starting material.
For nedsettelse av nucleinsyreinnholdet ble denne cellemasse suspendert i 900 ml vann. pH-verdien av den ved røring homogeniserte suspensjon utgjorde 6,9- To reduce the nucleic acid content, this cell mass was suspended in 900 ml of water. The pH value of the suspension homogenized by stirring was 6.9-
Etter økning av temperaturen til 55°C ble det ennu videre omrørt i 20 minutter, avkjølt ved 30°C og ved sentrifugering adskilt i fast og flytende faser. Det dannede sediment ble igjen blandet med 900 ml vann og omrørt 10 minutter ved 20°C. Deretter ble det igjen sentrifugert og sedimentet tørket under nedsatt trykk. After raising the temperature to 55°C, it was further stirred for 20 minutes, cooled at 30°C and separated into solid and liquid phases by centrifugation. The formed sediment was again mixed with 900 ml of water and stirred for 10 minutes at 20°C. It was then centrifuged again and the sediment dried under reduced pressure.
Utbyttet utgjorde 65 g. Nucleinsyreinnholdet var sunket fra det opprinnelige 11, 2 % til 1,5 %• Produktet var i tørr tilstand luktløst, fuktet med".vann hadde det en sympa-tisk lukt. The yield was 65 g. The nucleic acid content had decreased from the original 11.2% to 1.5%• The product was odorless in the dry state, moistened with water it had a sympathetic odor.
Resultatet av dette og de ytterligere eksempler er The result of this and the further examples is
sammenfattet i nedenstående tabeller Ia og IB. summarized in the tables Ia and IB below.
Eksempel 2. Example 2.
Som utgangsmateriale tjente samme bakteriecellemasse som ble anvendt i eksempel 1. Den ble underkastet de samme fremgangsmåtetrinn og betingelser imidlertid ble det istedenfor gassformet NH^ anvendt 30 ml konsentrert NH^OH (33 %-ig) som reagens. The same bacterial cell mass as was used in example 1 served as starting material. It was subjected to the same process steps and conditions, however, instead of gaseous NH 3 30 ml of concentrated NH 3 OH (33%-ig) was used as reagent.
Eksempel 3- Example 3-
Det ble gått frem som i eksempel 2, imidlertid ble det anvendt 60 ml konsentrert NH^OH ( 33 %-ig). The procedure was the same as in example 2, however, 60 ml of concentrated NH 3 OH (33% strength) was used.
Eksempel 4. Example 4.
Ved en fremgangsmåte som i eksempel 2 ble det istedenfor metanol anvendt etanol som oppløsningsmiddel. In a method as in example 2, ethanol was used as solvent instead of methanol.
Eksempel 5- Example 5-
Ved ellers samme fremgangsmåte som i eksempel 3 ble det istedenfor metanol anvendt glykolmonometyleter som opp-løsningsmiddel. In otherwise the same procedure as in example 3, glycol monomethyl ether was used as solvent instead of methanol.
Eksempel 6. Example 6.
Det ble gått frem_som i eksempel 2. Istedenfor metanol ble det anvendt i-propanol som oppløsningsmiddel. The procedure was as in example 2. Instead of methanol, i-propanol was used as solvent.
Eksempel 7• Example 7•
Som utgangsmateriale ble det anvendt en cellemasse av Metylomonas clar-a som omtalt i eksempel 1. 100 g av dette forstøvningstørkede produkt ble oppsluttet, avfettet (15 g NHy) som omtalt i eksempel 1. Imidlertid ble det sett bort fra den fullstendige tørkning av residuet. Den grundig frasugde filter-.kake med faststoffinnhold på 85 % ble suspendert i 900 ml vann. pH-verdien innstilte seg på 8,9, betinget ved den i den fuktige biomasse gjenblivne ammoniakk. As starting material, a cell mass of Metylomonas clar-a was used as described in Example 1. 100 g of this spray-dried product was digested, defatted (15 g NHy) as described in Example 1. However, the complete drying of the residue was disregarded . The thoroughly aspirated filter cake with a solids content of 85% was suspended in 900 ml of water. The pH value settled at 8.9, due to the ammonia remaining in the moist biomass.
Suspensjonens temperatur ble under omrøring øket The temperature of the suspension was increased while stirring
til 65°C og etter 5 minutter ble pH-verdien innstillet ved til-setning av HC1 til 7,2. Deretter ble det videre omrørt under 15 minutter ved 65°C, deretter avkjølt ved 40°C og sentrifugert. Det dannede sediment ble tørket. to 65°C and after 5 minutes the pH value was adjusted by the addition of HCl to 7.2. It was then further stirred for 15 minutes at 65°C, then cooled at 40°C and centrifuged. The sediment formed was dried.
Eksempel 8. Example 8.
_En hydrokarbonutnyttende stamme av gjæren Candida. lipolytica ATCC 20 383 ble kultivert på n-parafiner i nærvær av et vanndig næringsmedium og en oksygenholdig gass. Gjærcellemas-sen ble adskilt fra næringsoppløsningen og tørket. _A hydrocarbon-utilizing strain of the yeast Candida. lipolytica ATCC 20 383 was cultured on n-paraffins in the presence of an aqueous nutrient medium and an oxygen-containing gas. The yeast cell mass was separated from the nutrient solution and dried.
100 g av den tørre gjærcellemasse ble ved værelsetemperatur under normalt trykk suspendert i 300 g metanol og til denne blanding i løpet av 15 minutter tilført 10 g NH^-gass. Derved ble suspensjonens temperatur ved avkjøling holdt ved 15°C. Etter innføringen av gassen ble det videre omrørt ennu 20 minutter ved 22°C og deretter filtrert over en sugefritte. Filterkaken ble gjennomblandet en gang med 300 ml metanol på fritten og deretter frasuget. De to filtrater ble forenet. Opp-løsningen var gul og inneholdt lipidene av det anvendte cellematerial. Metanol og NH^ ble fjernet ved nedsatt trykk (14 torr). 100 g of the dry yeast cell mass was suspended at room temperature under normal pressure in 300 g of methanol and 10 g of NH 2 gas was added to this mixture within 15 minutes. Thereby, the suspension's temperature during cooling was kept at 15°C. After the introduction of the gas, it was further stirred for another 20 minutes at 22°C and then filtered over a suction frit. The filter cake was thoroughly mixed once with 300 ml of methanol on the frit and then aspirated. The two filtrates were combined. The solution was yellow and contained the lipids of the cell material used. Methanol and NH 3 were removed at reduced pressure (14 torr).
Det etter annen filtrering gjenblivne residu som besto av de ødelagte og avfettede celler av mikroorganismen b.le_ tørket i vakuumtørkeskap ved 40°C (100 torr) i 5 timer. Det,, således dannede produkt hadde en lysere farve enn den til å begyn-ne med anvendte gjærcellemasse og var uten lukt. The residue remaining after second filtration, which consisted of the destroyed and degreased cells of the microorganism, was dried in a vacuum drying cabinet at 40°C (100 torr) for 5 hours. The product thus formed had a lighter color than that to start with the yeast cell mass used and was odorless.
For nedsettelse av nucleinsyreinnholdet fra de opprinnelige 7,5 vekt-% referert til utgangsmaterialet ble 100 g av den avfettede og tørre gjær suspendert i en oppløsning av 1 liter destillert vann og 1000 ml metanol. Under omrøring ble blandingen ved en pH-verdi som innstiller seg på 6,8 i 15 minutter bragt til 50°C og sentrifugering oppdelt i et sediment som inneholdt gjærprotein og en flytende fase som inneholdt oppløse-liggjorte nucleinsyrer. Sedimentet ble etter gjentatt vasking To reduce the nucleic acid content from the original 7.5% by weight referred to the starting material, 100 g of the defatted and dry yeast were suspended in a solution of 1 liter of distilled water and 1000 ml of methanol. While stirring, the mixture was brought to 50°C at a pH value of 6.8 for 15 minutes and separated by centrifugation into a sediment containing yeast protein and a liquid phase containing dissolved nucleic acids. The sediment was after repeated washing
ved værelsetemperatur underkastet frysetørking. at room temperature subjected to freeze drying.
Det tørre materials nucleinsyreinnhold var sunket fra de opprinnelige 7,5 vekt-% til 0,4 vekt-%. The nucleic acid content of the dry material had dropped from the original 7.5% by weight to 0.4% by weight.
Eksempel 9- Example 9-
Ved en fremgangsmåte som i eksempel 8 ble det istedenfor metanol anvendt etanol og istedenfor 10 g NH^-gassformet 60 ml NH^OH (33 %-ig)'. In a method as in example 8, ethanol was used instead of methanol and instead of 10 g NH 3 gaseous 60 ml NH 3 OH (33%-ig)'.
Eksempel 10. Example 10.
Penicillium crysogenum ATCC 10 238 ble dyrket i en næringsoppløsning inneholdende lactose, flytende kornstøp, fos-fat, karbonat og magnesiumsulfat etter vanlige metoder. Etter adskillelse av det dannede penicillin,ble det tilbake mycel som tørket tjente som utgangsmateriale. Penicillium crysogenum ATCC 10 238 was grown in a nutrient solution containing lactose, liquid grain cast, phosphate, carbonate and magnesium sulphate according to usual methods. After separation of the penicillin formed, mycelium remained, which, when dried, served as starting material.
Fremgangsmåten ble gjennomført som i eksempel 8. Istedenfor NH^ ble det anvendt NH^OH (33 %-ig). Det avfettede tørrmycel ble vasket ved 30°C med vann. The procedure was carried out as in example 8. Instead of NH 2 , NH 2 OH (33%-ig) was used. The defatted dry mycelium was washed at 30°C with water.
Eksempel 11. Example 11.
Som utgangsmateriale tjente samme cellemasse som i eksempel 10. Istedenfor metanol ble det anvendt etanol. Temperaturen under vannekstraheringen ble øket til 85°C og holdt her i 15 minutter. The starting material was the same cell mass as in example 10. Instead of methanol, ethanol was used. The temperature during the water extraction was increased to 85°C and held here for 15 minutes.
I følgende tabell III er det oppført resultatene av eksemplene 1-11. The following table III lists the results of examples 1-11.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2633666A DE2633666C3 (en) | 1976-07-27 | 1976-07-27 | Reduction of the lipid and nucleic acid content in microbial cell mass |
Publications (3)
Publication Number | Publication Date |
---|---|
NO772658L NO772658L (en) | 1978-01-30 |
NO147034B true NO147034B (en) | 1982-10-11 |
NO147034C NO147034C (en) | 1983-01-19 |
Family
ID=5984032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO772658A NO147034C (en) | 1976-07-27 | 1977-07-26 | PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASSES |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS5315489A (en) |
AT (1) | AT357502B (en) |
AU (1) | AU512670B2 (en) |
BE (1) | BE857229A (en) |
BG (1) | BG37997A3 (en) |
CA (1) | CA1101724A (en) |
CH (1) | CH635615A5 (en) |
CS (1) | CS207473B2 (en) |
DD (1) | DD131072A5 (en) |
DE (1) | DE2633666C3 (en) |
DK (1) | DK146511C (en) |
EG (1) | EG12626A (en) |
ES (1) | ES460877A1 (en) |
FI (1) | FI57443C (en) |
FR (1) | FR2359896A1 (en) |
GB (1) | GB1584194A (en) |
GR (1) | GR64056B (en) |
HU (1) | HU176802B (en) |
IL (1) | IL52594A (en) |
IT (1) | IT1082226B (en) |
NL (1) | NL7708171A (en) |
NO (1) | NO147034C (en) |
PL (1) | PL107949B1 (en) |
PT (1) | PT66849B (en) |
RO (1) | RO71982A (en) |
SE (1) | SE432609B (en) |
SU (1) | SU791257A3 (en) |
ZA (1) | ZA774517B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2748885A1 (en) * | 1977-11-02 | 1979-05-03 | Hoechst Ag | PROCESS FOR IMPROVING THE PROPERTIES OF SCROTS OR FLOURS FROM OIL SEEDS |
DE2907065A1 (en) | 1979-02-23 | 1980-09-04 | Hoechst Ag | METHOD FOR GREATING LEATHER AND FUR SKINS |
CA1120314A (en) * | 1979-08-22 | 1982-03-23 | John A. Ridgway | Treatment of proteinaceous materials with anhydrous ammonia gas |
DE3143947A1 (en) * | 1981-11-05 | 1983-05-11 | Hoechst Ag, 6230 Frankfurt | "FUNCTIONAL PROTEIN HYDROLYSATE, METHOD FOR THE PRODUCTION THEREOF AND FOOD CONTAINING THIS PROTEIN HYDROLYSATE" |
DE3228500A1 (en) * | 1982-07-30 | 1984-02-02 | Basf Ag, 6700 Ludwigshafen | METHOD FOR PURIFYING CARBONIC ACID ESTERS CONTAINING ALDEHYDE, ACETALS AND / OR UNSATURATED COMPOUNDS |
EP0805201B1 (en) * | 1995-05-29 | 2000-01-12 | Otkrytoe Akcionernoe Obschestvo"Nauchno-Issledovatelsky Institut Vychislitelnykh Komplexov im. M.A. Karceva", | Method of obtaining a biomass of microorganisms with a low nucleic acids content |
RU2522888C2 (en) * | 2012-10-04 | 2014-07-20 | Валентина Еремеевна Куцакова | Method of production of protein feed additive |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3615654A (en) * | 1968-05-17 | 1971-10-26 | Cpc International Inc | Method of treating microbial cells |
IT954172B (en) * | 1970-07-24 | 1973-08-30 | Standard Oil Co | PROCEDURE FOR EXTRACTING PROTEIN MATERIAL FROM UNICELLULAR MICROBIAL ORGANISMS AND PRODUCT OBTAINED |
SU419551A1 (en) * | 1972-01-18 | 1974-03-15 | В. Ф. Фоменков Институт биологической физики СССР | THERMAL FLOW METER |
GB1400691A (en) * | 1973-02-08 | 1975-07-23 | British Petroleum Co | Process for the production of proteinaceous material |
GB1408845A (en) * | 1973-02-13 | 1975-10-08 | Ranks Hovis Mcdougall Ltd | Production of edible protein containing substances |
JPS5411379B2 (en) * | 1973-02-21 | 1979-05-15 |
-
1976
- 1976-07-27 DE DE2633666A patent/DE2633666C3/en not_active Expired
-
1977
- 1977-07-20 ES ES460877A patent/ES460877A1/en not_active Expired
- 1977-07-22 CH CH913977A patent/CH635615A5/en not_active IP Right Cessation
- 1977-07-22 BG BG036986A patent/BG37997A3/en unknown
- 1977-07-22 NL NL7708171A patent/NL7708171A/en not_active Application Discontinuation
- 1977-07-25 IT IT26084/77A patent/IT1082226B/en active
- 1977-07-25 DD DD7700200262A patent/DD131072A5/en unknown
- 1977-07-25 SE SE7708539A patent/SE432609B/en not_active IP Right Cessation
- 1977-07-25 GR GR54033A patent/GR64056B/en unknown
- 1977-07-25 FI FI772272A patent/FI57443C/en not_active IP Right Cessation
- 1977-07-25 IL IL52594A patent/IL52594A/en unknown
- 1977-07-25 EG EG439/77A patent/EG12626A/en active
- 1977-07-25 RO RO7791163A patent/RO71982A/en unknown
- 1977-07-26 HU HU77HO2006A patent/HU176802B/en unknown
- 1977-07-26 NO NO772658A patent/NO147034C/en unknown
- 1977-07-26 DK DK337677A patent/DK146511C/en not_active IP Right Cessation
- 1977-07-26 PL PL1977199855A patent/PL107949B1/en unknown
- 1977-07-26 AT AT544077A patent/AT357502B/en not_active IP Right Cessation
- 1977-07-26 SU SU772504953A patent/SU791257A3/en active
- 1977-07-26 PT PT66849A patent/PT66849B/en unknown
- 1977-07-26 AU AU27319/77A patent/AU512670B2/en not_active Expired
- 1977-07-26 CA CA283,487A patent/CA1101724A/en not_active Expired
- 1977-07-26 ZA ZA00774517A patent/ZA774517B/en unknown
- 1977-07-27 CS CS764982A patent/CS207473B2/en unknown
- 1977-07-27 JP JP8934977A patent/JPS5315489A/en active Granted
- 1977-07-27 GB GB31537/77A patent/GB1584194A/en not_active Expired
- 1977-07-27 BE BE179698A patent/BE857229A/en not_active IP Right Cessation
- 1977-07-27 FR FR7723082A patent/FR2359896A1/en active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2647895C3 (en) | Process for the production of 9à -hydroxyandrostenedione in a microbiological way | |
EP0081262A2 (en) | Process for the production of alpha-galactosidase and uses of the enzyme thus obtained | |
NO147034B (en) | PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASSES | |
US4206243A (en) | Process for reducing the contents of lipids and nucleic acid in microbial cell masses | |
US3183172A (en) | Obtaining psilocybin and psilocin from fungal material | |
EP0170880A1 (en) | Process for the production of aminooxidase-containing material or aminooxidase from microorganisms, such products and their use in the degradation of histamin in food and drinks | |
US2635069A (en) | Production of catalase from mold | |
US20040185157A1 (en) | Method for preparing oil and fat compositions comprising oleanolic acid and/or maslinic acid | |
HU185264B (en) | Improved microbiological process for producing androstane steroides | |
US2218971A (en) | Recovery of sterols | |
CA1118376A (en) | Process for producing steroidal alcohols | |
SU862830A3 (en) | Method of preparing 21-oxy-20-methylpregnane derivatives | |
EP0443925B1 (en) | Process for the microbiological obtention of irones | |
KR810001964B1 (en) | Process for reducing the contents of lipids and nucleic acid in mocrobial cell masses | |
GB2030441A (en) | Process for treating meals and flours of oily seeds | |
CN108822176A (en) | A kind of technique that enzyme process esterification free fatty acid extracts phytosterol | |
DE2303495A1 (en) | PROCESS FOR THE PRODUCTION OF ERGOSTERIN AND ITS ESTERS | |
CN108976305A (en) | A kind of solubility amidation soybean polyoses and preparation method thereof | |
JP2001299289A (en) | Method for producing sesame-treated product containing lignans | |
CN118256587A (en) | Method for producing 11 alpha-hydroxy progesterone by high-efficiency fermentation and conversion of progesterone | |
NO147878B (en) | PROCEDURE FOR THE EXTRACTION OF ZEARALENON. | |
CN117987202A (en) | Method for extracting tea seed oil by enzyme method | |
JPS5920358B2 (en) | High-yield production method for kasugamycin | |
JPS59198992A (en) | Purification of microorganism protein isolate | |
BE569390A (en) |